Rupprecht Anne, Moldzio Rudolf, Mödl Bernadette, Pohl Elena E
Institute of Physiology, Pathophysiology and Biophysics, Department of Biomedical Sciences, University of Veterinary Medicine, Vienna, Austria; Institute of Pharmacology and Toxicology, Rostock University Medical Center, Germany.
Institute of Medical Biochemistry, Department of Biomedical Sciences, University of Veterinary Medicine, Vienna, Austria.
Biochim Biophys Acta Bioenerg. 2019 May 1;1860(5):391-401. doi: 10.1016/j.bbabio.2019.03.006. Epub 2019 Mar 15.
Mitochondrial uncoupling protein 2 (UCP2) is highly abundant in rapidly proliferating cells that utilize aerobic glycolysis, such as stem cells, cancer cells, and cells of the immune system. However, the function of UCP2 has been a longstanding conundrum. Considering the strict regulation and unusually short life time of the protein, we propose that UCP2 acts as a "signaling protein" under nutrient shortage in cancer cells. We reveal that glutamine shortage induces the rapid and reversible downregulation of UCP2, decrease of the metabolic activity and proliferation of neuroblastoma cells, that are regulated by glutamine per se but not by glutamine metabolism. Our findings indicate a very rapid (within 1 h) metabolic adaptation that allows the cell to survive by either shifting its metabolism to the use of the alternative fuel glutamine or going into a reversible, more quiescent state. The results imply that UCP2 facilitates glutamine utilization as an energetic fuel source, thereby providing metabolic flexibility during glucose shortage. The targeting UCP2 by drugs to intervene with cancer cell metabolism may represent a new strategy for treatment of cancers resistant to other therapies.
线粒体解偶联蛋白2(UCP2)在利用有氧糖酵解的快速增殖细胞中高度丰富,如干细胞、癌细胞和免疫系统细胞。然而,UCP2的功能一直是个长期存在的难题。考虑到该蛋白的严格调控和异常短暂的寿命,我们提出UCP2在癌细胞营养缺乏时充当“信号蛋白”。我们发现谷氨酰胺缺乏会诱导UCP2快速且可逆地下调,降低神经母细胞瘤细胞的代谢活性和增殖,这是由谷氨酰胺本身而非谷氨酰胺代谢所调控的。我们的研究结果表明存在一种非常快速(在1小时内)的代谢适应,使细胞能够通过将代谢转变为使用替代燃料谷氨酰胺或进入可逆的、更静止的状态来存活。结果表明UCP2促进谷氨酰胺作为能量燃料源的利用,从而在葡萄糖缺乏时提供代谢灵活性。通过药物靶向UCP2以干预癌细胞代谢可能代表了一种治疗对其他疗法耐药的癌症的新策略。